Pay in 4 interest-free payments of $5.74 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Heres what the clinical evidence shows: Study Scope: 900+ participants across 6 randomized, double-blind, placebo-controlled trials Safety Profile: Indistinguishable from placebo in tolerability assessments Serious Events: Zero serious adverse events attributed to AOD-9604 Withdrawals: No treatment-related discontinuations in any trial Common Effects: Mild headache and minor GI symptoms at rates similar to placebo IGF-1 Impact: No effect on insulin-like growth factor-1 levels Metabolic Safety: No negative impact on glucose metabolism or insulin sensitivity Immunogenicity: Zero participants developed anti-AOD9604 antibodies The following analysis provides complete details on the clinical trial evidence supporting AOD-9604s favorable safety profile
Mounjaro is brand-name tirzepatide manufactured by Eli Lilly
Medicines Certain medicines used for other conditions may affect the absorption of vitamin B12
Lab-Tested Purity: Both peptides undergo rigorous third-party lab testing to ensure 100% purity and zero contaminants
Same formula, different dose ranges
%25201.png)
US$ 21.72
US$ 24.19
US$ 27.29
US$ 21.37
US$ 28.04
